http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7859893

Outgoing Links

Predicate Object
contentType Clinical Trial|Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 1036
issn 1572-0241
0002-9270
issueIdentifier 5
pageRange ajg2005177-1036
publicationName The American Journal of Gastroenterology
startingPage ajg2005177
bibliographicCitation Hawkey C, Talley NJ, Yeomans ND, Jones R, Sung JJ, Långström G, Naesdal J, Scheiman JM; NASA1 SPACE1 Study Group. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol. 2005 May;100(5):1028–36. doi: 10.1111/j.1572-0241.2005.41465.x. PMID: 15842575.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaa9871915662fa5168bbd1e2a3eaf26
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61da51729518768adea0a51213f33a88
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3eafef8bc38397f28c6aae19037c041d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0f98d3c823f814dee9d59ea008f7ae2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93d81b50204298d5713572d8ee7627dd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3125-5199
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc0e6049f96d313baa6701d6332956ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68d3b84162302a692e404994152a358b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_993457994bda624884499157b25bccd5
date 2005-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1111/j.1572-0241.2005.41465.x
https://pubmed.ncbi.nlm.nih.gov/15842575
isPartOf https://portal.issn.org/resource/ISSN/1572-0241
https://portal.issn.org/resource/ISSN/0002-9270
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/426
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Improvements with Esomeprazole in Patients with Upper Gastrointestinal Symptoms Taking Non-Steroidal Antiinflammatory Drugs, Including Selective COX-2 Inhibitors
discusses http://id.nlm.nih.gov/mesh/M0001340
http://id.nlm.nih.gov/mesh/M0480958
http://id.nlm.nih.gov/mesh/M0016376
http://id.nlm.nih.gov/mesh/M0427109
http://id.nlm.nih.gov/mesh/M0258705
http://id.nlm.nih.gov/mesh/M0013341
http://id.nlm.nih.gov/mesh/M0011758
http://id.nlm.nih.gov/mesh/M0025664
http://id.nlm.nih.gov/mesh/M0016932
http://id.nlm.nih.gov/mesh/M0446346
http://id.nlm.nih.gov/mesh/M0017803
http://id.nlm.nih.gov/mesh/M0001335
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9579578
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_25e7482d087cb6429609f07a507aa159
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9568614
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8830
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7655

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129288902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129288905

Total number of triples: 54.